Oruka Therapeutics, Inc. Common Stock (ORKA) Stock
NASDAQ · ORKA
93.38
Fundamentals
Market cap
$6.29B
Price / Earnings ratio
-47.3x
Price / Sales ratio
N/A
Price / Book ratio
5.6x
Return on assets
-0.3%
Ex-Dividend date
29 Aug 2024
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Oruka Therapeutics, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees68
CEODr. Lawrence Otto Klein Ph.D.
IPO DateAug 8, 1997
HeadquartersMenlo Park, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Lawrence Otto Klein Ph.D. | President, CEO & Director | 1983 |
| Mr. Paul T. Quinlan | General Counsel & Secretary | 1963 |
| Dr. Joana Goncalves M.D. | Chief Medical Officer | 1974 |
| Mr. Arjun Agarwal CPA | Senior VP of Finance & Treasurer | 1976 |
| Ms. Laura Sandler | Chief Operating Officer | 1977 |
| Mr. Alan Lada | VP of IR & Capital Markets | — |
| Mr. Christopher Finch | Senior VP and Head of Business Development & Strategy | — |
| Dr. Rajiv Panwar | Senior VP and Head of Chemistry, Manufacturing & Controls | — |
| Mr. Larry Todd Edwards | Chief Commercial Officer | 1963 |
Fundamentals
Valuation
Market cap$6.29B
Price-to-sales ratioN/A
Price-to-book value5.64
Price-earnings ratio-47.30
Return on Equity-26.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.03
Income Statement
Average volume843,508
EBITDA$-115.61M
1 year high (52w)$115.52
1 year low (52w)$14.89
Dividend
Ex dividend date29 Aug 2024
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



